Dartnell Jo, Paterson J Mark H, Magill Nicholas, Norman-Taylor Fabian
*Department of Paediatric Orthopaedics, Evelina London Children's Hospital, St Thomas' Hospital †Royal London Hospital, London, UK ‡King's Clinical Trials Unit, King's College, London, UK.
J Pediatr Orthop. 2014 Apr-May;34(3):295-9. doi: 10.1097/BPO.0000000000000146.
Painful hip displacement is difficult to treat in severe cerebral palsy. Proximal femoral resection (PFR) is an excellent procedure for pain relief but has a high rate of heterotopic ossification (HO). Indomethacin is the gold standard therapy used for prevention in hip and acetabular surgery. There is no evidence of its benefit in this complex patient group.
Forty-one consecutive patients with severe cerebral palsy underwent 52 primary PFRs for severe pain in 2 pediatric orthopaedic units in London, UK. Twenty-one patients received a prophylactic postoperative dose of indomethacin for the prevention of HO. Notes and radiographs were reviewed independently by 2 orthopaedic trainees.
The mean age of patients was 14.3 and 14.8 years in the group administered with and administered without indomethacin, respectively, and mean follow-up was 4.5 and 4.3 years. Five patients in each group developed HO. One patient in the indomethacin group was offered reexcision for HO but declined. Two in the nonindomethacin group were offered reexcision and one accepted and made a good recovery. There was no difference in pain relief between the groups and no correlation between the degree of HO and level of postoperative pain.
This study does not support the use of prophylactic indomethacin in severe cerebral palsy patients undergoing PFR. We also question the importance of HO in the outcome of this procedure.
Level III.
在重度脑瘫患者中,疼痛性髋关节脱位难以治疗。股骨近端切除术(PFR)是缓解疼痛的一种有效手术,但异位骨化(HO)发生率较高。吲哚美辛是髋关节和髋臼手术中用于预防的金标准疗法。尚无证据表明其对这类复杂患者群体有益。
在英国伦敦的2个小儿骨科单元,41例连续的重度脑瘫患者因严重疼痛接受了52次初次PFR手术。21例患者术后接受了预防性吲哚美辛治疗以预防HO。2名骨科实习医生独立查阅病历和X线片。
接受和未接受吲哚美辛治疗组患者的平均年龄分别为14.3岁和14.8岁,平均随访时间分别为4.5年和4.3年。每组各有5例患者发生HO。吲哚美辛组有1例患者因HO接受再次切除手术,但拒绝了。非吲哚美辛组有2例患者被建议再次切除,其中1例接受并恢复良好。两组之间在疼痛缓解方面无差异,HO程度与术后疼痛程度之间也无相关性。
本研究不支持在接受PFR手术的重度脑瘫患者中使用预防性吲哚美辛。我们还对HO在该手术结果中的重要性提出质疑。
III级。